Winter weather continued to interfere with supply as shipments and downstream logistics were delayed.
Note: Takes current trend since January 1, extrapolates forward, and cuts off at noted per day administered doses.
High likelihood of achieving effective herd immunity by mid-year.
Note: Assumes current acceleration of trend, capped at 3mm doses/day, with 50% of doses administered going to >65s.
The model suggests deaths are set to fall dramatically in the coming months as vaccinations of seniors (the most vulnerable group) spread.
Note: "Vulnerable" population is estimated Over 65s less estimated Over-65 Cases & Over-65 Vaccinations.
All states have distributed at least 60% of their doses and have given at least 10% of their population at least 1 dose.
Note: Share first injections as a share of total population.
Rapid improvement across metrics continues as deaths start to roll over sharply at a lag.
Information or opinions expressed herein are general and educational in nature and have been provided for information purposes only. Neither the information nor opinions expressed constitute investment or health advice and it is not intended, nor should it be considered, as an endorsement of any specific investment strategy.
The views expressed represent the opinions of Bespoke Investment Group, LLC and are not intended as a forecast or guarantee of future results. Past performance is no guarantee of future results. The information and opinions contained herein are current as of the date published and are subject to change without notice. Information has been obtained from sources believed to be reliable, but its accuracy, completeness, and interpretation are not guaranteed. Bespoke Investment Group, LLC is not affiliated with AMG Funds LLC nor any of its affiliates. Copyright © 2021 Bespoke Investment Group, LLC. All rights reserved. Reproduction and distribution is prohibited without express permission.
AMG Funds, LLC cannot guarantee that the information herein is accurate, complete, or timely. AMG Funds, LLC makes no warranties with regard to such information or results obtained by its use, and disclaims any liability arising out of your use of, or any reliance on, such information.
You are now leaving the AMG Funds web site: Please click OK below to leave the AMG Funds site and proceed to the selected site. AMG Funds does not endorse this web site, its sponsor, or any of the policies, activities, products or services offered on the site, or by any advertiser on the site. AMG Funds takes no responsibility for the accuracy or factual correctness of any information posted to third party web sites.OK